This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: The Ohio State University, The University of Manchester. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2025
Title: Innovations by Inventor Safdar Khan
Introduction
Safdar Khan is an accomplished inventor based in Columbus, OH (US). He has made significant contributions to the field of musculoskeletal health through his innovative research and patents. His work focuses on reprogramming diseased musculoskeletal cells, which has the potential to transform treatment methodologies in this area.
Latest Patents
Safdar Khan holds a patent titled "Compositions and methods for reprogramming diseased musculoskeletal cells." This patent discloses compositions and methods for reprogramming diseased musculoskeletal cells both in vitro and in vivo. In some embodiments, the disclosed method involves non-virally delivering intracellularly into the diseased musculoskeletal cells a polynucleotide comprising one or more nucleic acid sequences encoding one or more of the disclosed transcription factors. This innovative approach could pave the way for new therapeutic strategies.
Career Highlights
Throughout his career, Safdar Khan has worked with prestigious institutions, including The Ohio State University and The University of Manchester. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Devina Walter and Shirley Tang. Their collaborative efforts have further advanced the research and development of innovative solutions in musculoskeletal health.
Conclusion
Safdar Khan's contributions to the field of musculoskeletal health through his patent and collaborations highlight his role as a significant innovator. His work continues to inspire advancements in medical treatments and research methodologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile